No Data
No Data
ADRs Close Lower; BingEx Ltd. Declines 22%
European Equities Traded in the US as American Depositary Receipts Tread Water in Tuesday Trading
Adaptimmune Therapeutics Is Maintained at Buy by HC Wainwright & Co.
Adaptimmune Therapeutics: Balancing Positive Momentum With Strategic Pauses – A Hold Rating Analysis
Barclays Remains a Sell on Adaptimmune Therapeutics (ADAP)
Express News | Adaptimmune Therapeutics PLC : Guggenheim Cuts Target Price to $1.75 From $3
101674396 : No.. still have 25day’s plus..may chance to get RS